MedTrace Logo

Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients

NCT06012799 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-04-17

No results posted yet for this study

Summary

his study aims to utilize Continuous Glucose Monitoring (CGM) to observe glucose fluctuations in kidney transplant recipients and predict New-Onset Diabetes After Transplantation (NODAT) based on these patterns. Additionally, it seeks to investigate glucose variability resulting from medications and surgeries such as immunosuppressants and steroid regimens post-kidney transplantation. This prospective observational study anticipates identifying factors influencing blood glucose levels and contributing to future research on blood glucose management using CGM monitoring in kidney transplant patients.

Conditions

  • New Onset Diabetes After Transplantation

Interventions

DIAGNOSTIC_TEST

continuous glucose monitoring

FreeStyle Libre Flash Glucose Monitoring System

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2024-09-30
Completion
2024-12-30
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06012799 on ClinicalTrials.gov